Mesenchymal stromal cells for immunomodulatory cell therapy in liver transplantation: One step at a time

2017 ◽  
Vol 67 (1) ◽  
pp. 7-9 ◽  
Author(s):  
Jordi Colmenero ◽  
Pau Sancho-Bru
Keyword(s):  
Liver Transplantation ◽  
Cell Therapy ◽  
Mesenchymal Stromal Cells ◽  
Stromal Cells ◽  
One Step

Effects of hypoxia on osteogenic differentiation of mesenchymal stromal cells used as a cell therapy for avascular necrosis of the femoral head

Cytotherapy ◽  
2016 ◽  
Vol 18 (9) ◽  
pp. 1087-1099 ◽  
Author(s):  
Gabriela Ciapetti ◽  
Donatella Granchi ◽  
Caterina Fotia ◽  
Lucia Savarino ◽  
Dante Dallari ◽  
...  
Keyword(s):  
Femoral Head ◽  
Cell Therapy ◽  
Osteogenic Differentiation ◽  
Avascular Necrosis ◽  
Mesenchymal Stromal Cells ◽  
Stromal Cells ◽  
A Cell

Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy

2021 ◽  
Vol 28 (10) ◽  
pp. 1708-1725
Author(s):  
Mauro Krampera ◽  
Katarina Le Blanc
Keyword(s):  
Cell Therapy ◽  
Mesenchymal Stromal Cells ◽  
Stromal Cells

Mesenchymal stromal cells for immunoregulation after liver transplantation

2016 ◽  
Vol 21 (6) ◽  
pp. 541-549 ◽  
Author(s):  
Christian L. Johnson ◽  
Yorick Soeder ◽  
Marc H. Dahlke
Keyword(s):  
Liver Transplantation ◽  
Mesenchymal Stromal Cells ◽  
Stromal Cells

Mesenchymal Stromal Cell Therapy for Respiratory Complications of Extreme Prematurity

2018 ◽  
Vol 35 (06) ◽  
pp. 566-569 ◽  
Author(s):  
Bernard Thébaud
Keyword(s):  
Cell Therapy ◽  
Preterm Infants ◽  
Bronchopulmonary Dysplasia ◽  
Mesenchymal Stromal Cells ◽  
Stromal Cells ◽  
Organ Damage ◽  
Cell Therapies ◽  
Neonatal Lung ◽  
Neonatal Lung Injury ◽  
Early Phase Clinical Trials

AbstractBronchopulmonary dysplasia remains the main complication of extreme preterm birth. Research over the past 10 years suggests the potential for stem cell-based therapies to prevent and/or restore organ damage in extreme preterm infants. Mesenchymal stromal cells, in particular, have advanced as the forerunner among various cell therapies based on very promising preclinical studies in animal models of neonatal lung injury. Early phase clinical trials are now underway to determine the safety and feasibility of this cell therapy in preterm infants at risk of developing bronchopulmonary dysplasia. This review will summarize the current rationale for testing mesenchymal stromal cells in this patient population and highlight the gaps in our knowledge to safely harness the full repair potential of cell-based therapies.

Strategies to improve the migration of mesenchymal stromal cells in cell therapy

2017 ◽  
Vol 3 (3) ◽  
pp. 159-175
Author(s):  
Gaigai Li ◽  
Gaigai Li ◽  
Yang Hu ◽  
Yanfang Chen ◽  
Zhouping Tang ◽  
...  
Keyword(s):  
Cell Therapy ◽  
Mesenchymal Stromal Cells ◽  
Stromal Cells

scholarly journals Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I–II, open-label, clinical study

2017 ◽  
Vol 67 (1) ◽  
pp. 47-55 ◽  
Author(s):  
Olivier Detry ◽  
Morgan Vandermeulen ◽  
Marie-Hélène Delbouille ◽  
Joan Somja ◽  
Noella Bletard ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Clinical Study ◽  
Phase I ◽  
Mesenchymal Stromal Cells ◽  
Stromal Cells ◽  
Open Label
Sign in / Sign up

Export Citation Format

Share Document